SLXN (Silexion Therapeutics) Pre-Tax Income : $-16.51 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Silexion Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Silexion Therapeutics's pretax income for the three months ended in Dec. 2024 was $-1.75 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-16.51 Mil. Silexion Therapeutics's pretax margin was %.

Silexion Therapeutics Pre-Tax Income Historical Data

The historical data trend for Silexion Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silexion Therapeutics Pre-Tax Income Chart

Silexion Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Pre-Tax Income

-3.46

-5.08

-16.51

Silexion Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial				-1.67	-1.42	-1.49	-11.86	-1.75

Competitive Comparison of Silexion Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Silexion Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Silexion Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Silexion Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Silexion Therapeutics's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Silexion Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Silexion Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-12.571	+	0.903	+	-0.007	+	0.001	+	-4.835
	=	-16.51

Silexion Therapeutics's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.9	+	0.18	+	-0.002	+	-0.024	+	0
	=	-1.75

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.51 Mil.

Silexion Therapeutics (NAS:SLXN) Pre-Tax Income Explanation

Silexion Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.746	/	0
	=	%

Silexion Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Silexion Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Silexion Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Silexion Therapeutics Corp (NAS:SLXN) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ha mayan Street, Modi in-Maccabim-Reut, ISR, 7177871

Website

https://www.silexion.com

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.